- Home
- NSTS vs IPSC Comparison
NSTS vs IPSC Comparison
Compare NSTS & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSTS
- IPSC
- Stock Information
- Founded
- NSTS 1921
- IPSC 2019
- Country
- NSTS United States
- IPSC United States
- Employees
- NSTS N/A
- IPSC N/A
- Industry
- NSTS Savings Institutions
- IPSC Medicinal Chemicals and Botanical Products
- Sector
- NSTS Finance
- IPSC Health Care
- Exchange
- NSTS Nasdaq
- IPSC Nasdaq
- Market Cap
- NSTS 65.8M
- IPSC 58.1M
- IPO Year
- NSTS N/A
- IPSC 2021
- Fundamental
- Price
- NSTS N/A
- IPSC $0.54
- Analyst Decision
- NSTS
- IPSC Strong Buy
- Analyst Count
- NSTS 0
- IPSC 5
- Target Price
- NSTS N/A
- IPSC $3.67
- AVG Volume (30 Days)
- NSTS 2.7K
- IPSC 551.0K
- Earning Date
- NSTS 05-12-2025
- IPSC 05-08-2025
- Dividend Yield
- NSTS N/A
- IPSC N/A
- EPS Growth
- NSTS N/A
- IPSC N/A
- EPS
- NSTS N/A
- IPSC N/A
- Revenue
- NSTS $8,931,000.00
- IPSC $6,589,000.00
- Revenue This Year
- NSTS N/A
- IPSC $833.10
- Revenue Next Year
- NSTS N/A
- IPSC N/A
- P/E Ratio
- NSTS N/A
- IPSC N/A
- Revenue Growth
- NSTS 82.49
- IPSC 194.81
- 52 Week Low
- NSTS $9.37
- IPSC $0.34
- 52 Week High
- NSTS $13.32
- IPSC $3.70
- Technical
- Relative Strength Index (RSI)
- NSTS 60.88
- IPSC 53.48
- Support Level
- NSTS $10.80
- IPSC $0.34
- Resistance Level
- NSTS $12.22
- IPSC $0.54
- Average True Range (ATR)
- NSTS 0.26
- IPSC 0.05
- MACD
- NSTS 0.12
- IPSC 0.02
- Stochastic Oscillator
- NSTS 98.45
- IPSC 93.95
About NSTS NSTS Bancorp Inc.
NSTS Bancorp Inc is a savings and loan holding company regulated Federal Reserve Board. The company was formed to serve as the North Shore Trust and Savings stock holding company. The Bank is a wholly-owned subsidiary of the company and operates as a traditional savings institution focused on serving the banking needs of customers in our market area of Lake County, Illinois and adjacent communities.
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases. Their innovative approach involves a genetically engineered allogeneic cell therapy platform comprising induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to overcome the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and minimizing development and supply risks.